Baricitinib as Treatment for Coronavirus Disease 2019 (COVID-19): Friend or Foe of the Pancreas?

Cerda-Contreras, Christopher; Nuzzolo-Shihadeh, Laura; Camacho-Ortiz, Adrián; Perez-Alba, Eduardo

Cerda-Contreras, Christopher; Nuzzolo-Shihadeh, Laura; Camacho-Ortiz, Adrián; Perez-Alba, Eduardo.

Cerda-Contreras C; Servicio de Medicina Interna, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey Mexico.
Nuzzolo-Shihadeh L; Servicio de Infectología, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey Mexico.
Camacho-Ortiz A; Servicio de Infectología, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey Mexico.
Perez-Alba E; Servicio de Infectología, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey Mexico.

Clin Infect Dis ; 73(11): e3977-e3978, 2021 12 06.

Article in English | MEDLINE | ID: covidwho-1561969

Subject(s)

COVID-19 Drug Treatment; Azetidines; Humans; Pancreas; Purines; Pyrazoles; SARS-CoV-2; Sulfonamides

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google